Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... debris and components, concentration to separate and recover the target product by reducing volume, and final purification using chromatographic techniques. Downstream processing plays a critical role in ensuring the purity, quality, and stability of biopharmaceutical ... Read More
-
Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... They provide benefits such as reducing the risks of cross-contamination, minimized clean-in-place and sterilization cycles, and lower capital costs. With rising demand for biologics in the biopharmaceutical industry, more manufacturers are adopting single-use technologies to ... Read More
-
Biohacking Market, By Type (Inside and Outside), By Product (Smart Drugs, Sensors, Strains, Others), By Application (Synthetic Biology, Genetic Engineering, Forensic Science, Diagnosis & Treatment, Drug Testing), By End User (Biopharmaceutical Companies, Forensic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... hacking techniques such as quantifying health, gene editing, microbiome manipulation, and cognitive enhancements. Growing interest among people to take control of their health and optimize human performance through novel bio-enabled technologies boosts demand for biohacking ... Read More
-
Surgical Meshes Global Market Opportunities And Strategies To 2034 Including: 1) By Product Type: Synthetic Surgical Meshes; Biosynthetic Surgical Meshes; Biologic Surgical Meshes; Hybrid Or Composite Surgical Meshes 2) By Nature: Absorbable Surgical Meshes; Non-Absorbable Surgical Meshes; Partially Absorbable Surgical Meshes 3) By Sales Channel: Direct Channel; In-Direct Channel 4) By Application: Hernia Repair; Traumatic Or Surgical Wounds; Abdominal Wall Reconstruction; Facial Surgery 5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics Covering: Medtronic plc; Boston Scientific Corporation; Johnson & Johnson Services Inc.; Becton, Dickinson and Company; Lepu Medical Technology (Beijing) Co. Ltd.
... it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being affected by ... Read More
-
MEA Biologics and Biosimilars Market - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
... forecast period. This market growth is fueled by the rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, which drives the demand for advanced therapeutic solutions. Biologics provide targeted and effective treatments, ... Read More
-
Global Biopharmaceutical Analytical Testing Services Market 2025-2029
... the biopharmaceutical analytical testing services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Cell Culture Market, By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Tissue Culture & Engineering, Toxicity Testing, Drug Development, Cell & Gene Therapy, and Others), By End User (Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, CMO & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... seen significant growth in the last few decades driven by advancements in biomedical research and therapeutics development. Cell culture involves growing living cells in a specially formulated growth media under controlled conditions and has various ... Read More
-
Precision Medicine Market, By Application (Oncology, Central Nervous System, Hematology , Immunology , Respiratory , and Others), By Technology (Bioinformatics, Gene Sequencing, Precision Molecular Diagnostics, Big Data Analytics, and Others), By End User (Biopharmaceutical Companies, Diagnostic Laboratories, Academic & Research Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies ... Read More
-
Global Biologics and Biosimilars Industry Growth and Trends Forecast to 2031
... this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is ... Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is ... Read More
-
Biologics and Biosimilars Industry Research Report 2025
... this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is ... Read More
-
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2025-2033
... 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market. ... Read More
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Inflammatory Bowel Disease Treatment Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
... 2033. Increased disease prevalence, improvements in biologic medicines, increased awareness, better diagnostics, and rising healthcare spending on specialist treatments are all factors propelling the market for treatments for inflammatory bowel disease. The report Inflammatory Bowel ... Read More
-
Innovation Insights: AI in antibody/biologics discovery
... this area has been consistently growing since 2018, with a significant increase in 2023. The rapid growth is attributed to the rise in AI technology, with a technology cycle time of 1.1 years. China and ... Read More
-
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030
... an estimated value of USD 883.97 billion by 2030. This growth can be attributed to the rising prevalence of chronic diseases, increasing geriatric population, growing healthcare expenditure by government organizations, and extensive efforts to improve ... Read More
-
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2025-2031
... expected to grow at a CAGR of 9.0% from 2025 to 2031. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Biotechnology Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
Metaverse in Healthcare Market by Component (Software, Hardware and Services), Type of Technology (Augmented Reality / Virtual Reality, Artificial Intelligence, Blockchain Technology, Mixed Reality and Other Technologies), Applications (Telehealth, Medical Training and Education, Drug Discovery and Personalized Medicine, Diagnosis, and Other Applications), End Users (MedTech Companies, Healthcare Providers, Biopharmaceutical, Biotechnology and Life Sciences Companies, Payers, and Patients), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America) and Key Players: Industry Trends and Global Forecasts, Till 2035
... at a CAGR of 31. 1% during the forecast period, till 2035. The opportunity for metaverse in healthcare market has been distributed across the following segments: Type of Technology Augmented Reality / Virtual Reality Artificial ... Read More
-
Global Biopharmaceutical Contract Manufacturing Market - Focused Insights 2024-2029
... of the leading CMO invested over $1 billion investment in biomanufacturing in France to enhance medicine production capabilities in France. In 2023, GTP Bioways opened two new biopharmaceutical production facilities in France. In 2024, Lonza ... Read More
-
Agricultural Biologics Global Market Report 2025
... And Pulses; Fruits And Vegetables; Turf And OrnamentalsCovering: Syngenta AG; Dow Chemical Company; Bayer AG; BASF SE; Isagro SPA Agricultural Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Biopharmaceutical CMO Global Market Report 2025
... Inc.; Thermo Fisher Scientific Inc.; Samsung Biologics; WuXi AppTec Biopharmaceutical CMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
-
Healthcare IT Outsourcing Market Report by Type (Payers HCIT Outsourcing, Providers HCIT Outsourcing), End User (Healthcare Provider System, Biopharmaceutical Industry, Clinical Research Organization, and Others), and Region 2025-2033
... reached USD 54.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 103.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.34% during 2025-2033. The increasing complexity of healthcare IT ... Read More
Research Assistance
